Sichuan Hebang Biotechnology Corporation Limited
603077.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | CN¥6,999 | CN¥3,064 | CN¥4,591 | CN¥1,711 |
| Short-Term Investments | CN¥0 | CN¥0 | CN¥0 | CN¥57 |
| Receivables | CN¥2,073 | CN¥2,049 | CN¥2,568 | CN¥1,656 |
| Inventory | CN¥4,545 | CN¥4,403 | CN¥2,076 | CN¥912 |
| Other Curr. Assets | CN¥181 | CN¥338 | CN¥483 | CN¥307 |
| Total Curr. Assets | CN¥14,003 | CN¥9,855 | CN¥9,719 | CN¥4,643 |
| Property Plant & Equip (Net) | CN¥9,952 | CN¥9,806 | CN¥9,483 | CN¥8,295 |
| Goodwill | CN¥1,838 | CN¥1,838 | CN¥1,838 | CN¥1,904 |
| Intangibles | CN¥2,562 | CN¥2,200 | CN¥2,171 | CN¥1,967 |
| Long-Term Investments | CN¥857 | CN¥667 | CN¥677 | CN¥605 |
| Tax Assets | CN¥127 | CN¥50 | CN¥110 | CN¥26 |
| Other NC Assets | CN¥309 | CN¥25 | CN¥104 | CN¥481 |
| Total NC Assets | CN¥15,646 | CN¥14,688 | CN¥14,384 | CN¥13,279 |
| Other Assets | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Total Assets | CN¥29,650 | CN¥24,542 | CN¥24,103 | CN¥17,922 |
| Liabilities | – | – | – | – |
| Payables | CN¥2,108 | CN¥1,877 | CN¥1,877 | CN¥1,156 |
| Short-Term Debt | CN¥2,353 | CN¥1,168 | CN¥1,222 | CN¥1,171 |
| Tax Payable | CN¥35 | CN¥55 | CN¥138 | CN¥223 |
| Deferred Revenue | CN¥0 | CN¥0 | CN¥234 | CN¥661 |
| Other Curr. Liab. | CN¥802 | CN¥451 | CN¥426 | CN¥425 |
| Total Curr. Liab. | CN¥5,375 | CN¥3,670 | CN¥3,734 | CN¥3,123 |
| LT Debt | CN¥4,935 | CN¥431 | CN¥408 | CN¥68 |
| Deferred Rev, NC | CN¥130 | CN¥0 | CN¥79 | CN¥17 |
| Deferred Tax Liab, NC | CN¥188 | CN¥123 | CN¥96 | CN¥40 |
| Other NC Liab. | CN¥1 | CN¥76 | CN¥0 | CN¥0 |
| Total NC Liab. | CN¥5,269 | CN¥654 | CN¥605 | CN¥162 |
| Other Liabilities | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Cap. Leases | CN¥15 | CN¥25 | CN¥22 | CN¥37 |
| Total Liabilities | CN¥10,643 | CN¥4,324 | CN¥4,339 | CN¥3,285 |
| Equity | – | – | – | – |
| Pref Stock | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Common Stock | CN¥8,831 | CN¥8,831 | CN¥8,831 | CN¥8,831 |
| Retained Earnings | CN¥9,478 | CN¥9,505 | CN¥8,825 | CN¥5,293 |
| AOCI | CN¥1,139 | CN¥66 | CN¥1,282 | CN¥608 |
| Other Equity | CN¥0 | CN¥847 | CN¥1,252 | CN¥5 |
| Total Equity | CN¥18,626 | CN¥19,575 | CN¥19,118 | CN¥14,245 |
| Supplemental Information | – | – | – | – |
| Minority Interest | CN¥380 | CN¥643 | CN¥645 | CN¥392 |
| Total Liab. & Tot. Equity | CN¥29,650 | CN¥24,542 | CN¥24,103 | CN¥17,922 |
| Net Debt | CN¥289 | -CN¥1,466 | -CN¥2,962 | -CN¥472 |